![Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects - ScienceDirect Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641198000228-gr1.gif)
Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects - ScienceDirect
![Pharmaceutics | Free Full-Text | 3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy Pharmaceutics | Free Full-Text | 3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00931/article_deploy/html/images/pharmaceutics-14-00931-g010.png)
Pharmaceutics | Free Full-Text | 3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy
![PDF) Levodopa delivery from controlled-release polymer matrix: Delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats PDF) Levodopa delivery from controlled-release polymer matrix: Delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats](https://i1.rgstatic.net/publication/20913430_Levodopa_delivery_from_controlled-release_polymer_matrix_Delivery_of_more_than_600_days_in_vitro_and_225_days_of_elevated_plasma_levels_after_subcutaneous_implantation_in_rats/links/0912f4fdeda83ec349000000/largepreview.png)
PDF) Levodopa delivery from controlled-release polymer matrix: Delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats
![PDF) A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease PDF) A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease](https://www.researchgate.net/profile/Douglas-Macmahon/publication/20972837/figure/tbl1/AS:601752357335076@1520480350839/Adverse-events-reported-during-the-study_Q320.jpg)
PDF) A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease
Madopar 250/Madopar HBS/Madopar Dispersible 125 Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
![Madopar HBS Levodopa / Benserazide 100 mg / 25 mg Controlled Release Capsule 100's - Buy with UnaPharma Madopar HBS Levodopa / Benserazide 100 mg / 25 mg Controlled Release Capsule 100's - Buy with UnaPharma](https://unapharma.ph/images/detailed/45/Madopar_HBS_125_mg_Tablet.jpg)